International Stem Cell Corporation (OTCBB:ISCO) http://www.internationalstemcell.com, a California-based biotechnology company focused on therapeutic and research products, announced today the selection of the Richards Partners as agency of record for its wholly owned subsidiary Lifeline Skin Care, Inc. ("Lifeline"). Lifeline offers luxury anti-aging skin care products based on its proprietary stem cell technology. Based in Dallas, the Richards Partners is the nation's largest independent branding agency.

Lifeline's skin care products were developed by a team of ISCO research scientists in collaboration with world-renowned cosmetic experts, and offer a comprehensive approach to skin care using patent pending moisture serums for day and night use. Made with human parthenogenetic stem cell extracts, the serums deliver anti-aging benefits, resulting in healthier and younger-looking skin. These products were launched in November 2010 and are available for purchase through the http://www.lifelineskincare.com website and selected luxury spas across the United States.

Adding Richards Partners to the Lifeline Skin Care^TM team is part of Lifeline's plan to build on its initial successful product launch last year, and the Web based sales that have followed, by initiating a series of new marketing campaigns to further develop the Lifeline Skin Care^TMbrand identity. These new marketing initiatives include traditional print and news media campaigns, as well as a new digital strategy focused on Internet and social media. "We are looking forward to working closely with the Richards Partners and leveraging their expertise in these areas to enhance the profile of Lifeline Skin Care^TM and its revolutionary new skin care products," says Lifeline CEO Ruslan Semechkin, PhD. "Building a globally recognizable brand is a long-term process and this is an important step towards creating Lifeline's name. We believe this is a good time to begin these campaigns and continue our sales momentum resulting from our successful initial launch," Dr. Semechkin continued.

As previously announced the Mauldin Group, Lifeline's marketing partner, will be managing the day to day relationship with the Richards Partners and planning additional direct marketing initiatives similar to the successful initial launch in 2010. Tiffani Mauldin-Frederick, marketing partner of Lifeline Skin Care^TM, says, "We're excited about working together with Richards Partners. We believe the collaboration will provide additional momentum and increase brand recognition for Lifeline Skin Care^TM and help educate the public about the revolutionary science behind these products."

ABOUT INTERNATIONAL STEM CELL CORPORATION (ISCO.OB)

International Stem Cell Corporation is a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing sexes, ages and racial groups. This offers the potential to create the first true stem cell bank, UniStemCell™, while avoiding the ethical issue of using fertilized eggs. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at ISCO's website, http://www.internationalstemcell.com.

To subscribe to receive ongoing corporate communications please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.

FORWARD-LOOKING STATEMENTS

Statements pertaining to anticipated developments, product introduction plans and related support, the potential benefits of products, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products and the management of collaborations, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.

Key Words: Stem cells, parthenogenesis, biotechnology, skin care, anti-aging

International Stem Cell Corporation
Kenneth C. Aldrich, Chairman
1-760-940-6383
kaldrich@intlstemcell.com
or
Lifeline Skin Care, Inc.
Ruslan Semechkin, PhD, President & CEO
Vice President, ISCO
ras@intlstemcell.com

Cancers often spread from their primary site (the part of the body in which the cancer started) to one or more metastatic sites (other parts of the body). Cancers are named according to their primary site, regardless of where in the body they spread. For example, a lung cancer that spreads to the lymph nodes, adrenal glands, and the liver is still classified as lung cancer and not as a lymphoma (cancer of the lymph nodes), adrenal cancer, or liver cancer.

A small number of cancers first appear in one or more metastatic sites, and the primary site is not known. These cancers are called cancer of unknown primary (CUP). The primary site of some of these cancers may eventually be found by additional tests. When this happens, they are no longer considered a cancer of unknown primary and are renamed according to the newly discovered site of origin. Read more...

Immunice for Immune Support

http://www.cellmedicine.com stem cell therapy. Here we are discussing a publication showing bone marrow mesenchymal stem cells reduce kidney damage. Mesenchymal stem cells may have promise for treating diabetic renal failure.

Read the original here:
Stem Cell Therapy for Kidney Failure

For those still contemplating whether or not the radiation emitted from airport naked body scanners is serious enough to avoid, you may be interested to know that many doctors routinely "opt out" and choose the full-body pat down instead because they recognize the inherent dangers associated with any level of radiation exposure. A recent CNN piece explains that for many doctors, avoiding all sources of radiation whenever possible is just the smart thing to do.

Throughout the past year, was covered many stories related to the US Transportation Security Administration's (TSA) controversial naked body scanners, which are now installed and in use at nearly 80 US airports (http://www.tsa.gov/approach/tech/ait/faqs.shtm). Besides representing an unconstitutional invasion of privacy (http://www.tsa.gov/approach/tech/ait/faqs.shtm), the scanners blast passengers with full-body doses of health-destroying radiation (http://www.dreddyclinic.com/forum/viewtopic.php?f=2&t=22309).

So what do medical doctors who fly have to say about the machines? Well, according to CNN's Elizabeth Cohen who recently conducted her own small investigation, many are concerned about the radiation these scanners emit. Read more...

Joint Mender for Joint Care

In 2011, the world will emit more than 35 billion tons of carbon dioxide. Every day of the year, almost a hundred million tons will be released into the atmosphere. Every second more than a thousand tons – two million pounds – of carbon dioxide is emitted from power plants, cars, trucks, ships, planes, factories, and farms around the world. The average citizen of the world will account for the release of four and a half tons – 9,000 pounds – of CO 2 this year. The average American will be responsible for four times as much, almost 18 tons, or 36,000 pounds of carbon dioxide this year, roughly a hundred pounds of carbon dioxide emissions for every day of the year.

While humans emit far less carbon dioxide than nature, the amount we emit exceeds the capacity of plants and oceans to absorb on top of the amount they’re already absorbing from natural sources. As a result, most of the carbon dioxide we emit remains in the atmosphere. Year over year, the atmospheric concentration of CO 2 creeps up. It will rise only half a percent in 2011, a seemingly tiny change. Yet tiny changes add up. Over the 50 years since 1960, the amount of carbon dioxide in the atmosphere has risen nearly 25%. Since the start of the industrial revolution it has risen by 45%, putting it at a level not seen in millions of years.

[More]

Some 3.2 million Americans have chronic hepatitis C , an infection that can linger in the body for years before producing symptoms. It can eventually lead to serious liver scarring and cancer. And most infections in the U.S. are the disease's particularly tough breed, known as genotype 1, which has a cure rate of less than 40 percent with the best current treatment. [More]

stemcell.md Meet Sam, a visual artist who was confronted with the one thing a man in his profession fears most: Compromised vision.

Go here to see the original:
Macular Degeneration Improved With Stem Cells

Dr. Roger Nocera discusses the healing mechanisms of adult stem cells. He also examines stem cell medicine in the context of historical advances in medicine.

See more here:
Cells That Heal Us From Cradle To Grave: A Quantum Leap in Medical Science

Visit: tinyurl.com for more pet stories -- A new technique for fighting the crippling effects of severe hip dysplasia is catching the attention of many large breed dog owners.

Go here to read the rest:
Dogged by pain -- stem cell therapy for dogs

Opposite to good carbohydrate (= "Slow Carbs”), bad carbohydrates – in neo-German also known as “Fast Carbs“ – cause the blood sugar level to rise quickly.
The faster – and thus the higher concentrated – carbohydrates are, the more insulin our body will produce in order to lower the blood sugar level.

As a consequence thereof, the blood sugar level will drop below normal, the appetite – in particular for sweets – will increase, and fat burning will be restricted during this «insulin fattening».

Therefore, GI and GL were invented, to facilitate distinction between «bad» and «good» carbohydrates.

Glycemic Index (GI)
The glycemic index – in short GI – is exclusively applied to foods containing carbohydrates. The GI does not rate foodstuffs with respect to their carbohydrate content but provides figures on their respective blood sugar level increasing effects. Read more...

Immunice for Immune Support

The sun strikes every square meter of our planet with more than 1,360 watts of power. Half of that energy is absorbed by the atmosphere or reflected back into space. 700 watts of power, on average, reaches Earth’s surface. Summed across the half of the Earth that the sun is shining on, that is 89 petawatts of power. By comparison, all of human civilization uses around 15 terrawatts of power, or one six-thousandth as much. In 14 and a half seconds, the sun provides as much energy to Earth as humanity uses in a day.

The numbers are staggering and surprising. In 88 minutes, the sun provides 470 exajoules of energy, as much energy as humanity consumes in a year. In 112 hours – less than five days – it provides 36 zettajoules of energy – as much energy as is contained in all proven reserves of oil, coal, and natural gas on this planet.

[More]

U.S. Supreme Court, ruling allows shareholders to sue Pharma and biotechnology companies for failing to report adverse drug events/ dangerous side effects.

Maker of homeopathic remedies Matrixx Initiatives, was sued by investors once it came to know their marketed nasal spray linked to a string of instances in which people using the treatment lost their sense of smell. The adverse events were reported back to the company by several medical professionals and patients, but never amounted to a statistically significant group. Matrixx argued it wasn’t responsible for reporting scattered and unreliable anecdotal evidence of adverse events. But the supremed court said No

http://www.bloomberg.com/news/2011-03-22/drugmaker-investor-lawsuits-backed-by-u-s-supreme-court-4-.html

Compare that to the Indian Law System

Madras High Court in India allowed a stay on immediate withdrawal of drugs banned  due to Severe Side Effects. The  pediatric doses of pain reliever nimesulide and anti-cold medicine phenylpropanolamine banned in  market due to harmful side effects, Indian Drugs Manufacturers Association & Confederation of Indian Pharmaceutical Industries put revenue loss to industry above safety of patients & managed to get a reversal of the ban.

http://www.business-standard.com/india/news/hc-stayimmediate-withdrawalbanned-drugs/429458/